OT ULTRAMINI METER
Report
- Report Number
- 2939301-2014-17990
- Event Type
- Injury
- Date Received
- July 21, 2014
- Report Date
- July 11, 2014
- Manufacturer
- LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
- Product Code
- NBW
- PMA / PMN Number
- K061118
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER
Narratives
THE METER INVOLVED WITH THIS COMPLAINT HAS BEEN RETURNED ON 07/25/2014 AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS ON 07/29/2014 WITH THE FOLLOWING FINDINGS: THE METER HAS PASSED TESTING WITH NO FAULTS FOUND. IF LIFESCAN OBTAINS ADDITIONAL INFORMATION REGARDING THIS COMPLAINT, A FOLLOW UP REPORT WILL BE SUBMITTED. AT THIS TIME, LIFESCAN CONSIDERS THIS MATTER CLOSED.
LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.
ON (B)(6) 2014, THE LAY-USER/PATIENT CONTACTED LIFESCAN (LFS) USA, ALLEGING THAT SHE TESTING IN THE MEMORY MODE, USE ERROR ISSUE. THIS COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CA) DOCUMENTATION. THE REPORTED ISSUE BEGAN ON (B)(6) 2014 AT 9 AM. THE PATIENT CLAIMED THAT DUE TO THE TESTING IN THE MEMORY MODE ISSUE, SHE DEVELOPED SYMPTOMS DESCRIBED AS ¿SHAKY.¿ THE PATIENT DID NOT BASE HER DIABETES MANAGEMENT ON THE SUBJECT METER AND DID NOT REQUIRE ANY MEDICAL INTERVENTION. DURING TROUBLESHOOTING, THE ISSUE WAS RESOLVED WITH TRAINING. THIS COMPLAINT IS BEING REPORTED DUE TO A POSSIBLE USE ERROR AND BECAUSE THE PATIENT HAD SYMPTOM THAT CAN BE SUGGESTIVE OF HYPOGLYCEMIA AFTER SHE ENCOUNTERED THE TESTING IN MEMORY MODE ISSUE. THE LFS PRODUCTS WERE REPLACED AND REQUESTED BACK FOR INVESTIGATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 425318 | OT ULTRAMINI METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL | 3640810 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Life Threatening |